Flutisal 50 mcg+250 mcg (Inhalation Capsule)
Unit Price: ৳ 12.00 (5 x 6: ৳ 360.00)
Strip Price: ৳ 72.00
Medicine Details
Category | Details |
---|---|
Generic | Salmeterol fluticasone propionate |
Company | Incepta pharmaceuticals ltd |
Also available as |
Indications
- Regular treatment of asthma
- Combination product for inadequately controlled asthma
- Long-acting β2-agonist therapy
- Inhaled corticosteroid therapy
- Asthma control with inhaled corticosteroids
- Asthma control with long-acting β2-agonist
Pharmacology
- Salmeterol Xinafoate as long-acting beta-2 agonist
- Fluticasone Propionate as corticosteroid with glucocorticoid activity
- Salmeterol mechanism of action as long-acting beta-2-adrenoceptor agonist
- Fluticasone Propionate anti-inflammatory action within the lungs
Dosage
- Adult dosage for Salmeterol and Fluticasone Propionate inhaler
- Pediatric dosage for Salmeterol and Fluticasone Propionate inhaler
- Recommended starting dosages
- Maximum recommended dosage
- Dosage for COPD patients
- Dosage for Maxhaler in asthma and COPD patients
Administration
- Proper use of Inhaler
- Steps for effective use of Inhaler
- Instructions for cleaning Inhaler
Interaction
- Avoidance of non-selective and selective β-blockers in asthma patients
- Potential drug interactions with strong CYP3A4 inhibitors
Contraindications
- History of hypersensitivity to salmeterol xinafoate or fluticasone propionate
- Primary treatment of status asthmaticus or acute episodes of asthma
Side Effects
- Expected adverse reactions with Salmeterol and Fluticasone Propionate
- Side effects of beta-2-agonist treatment
- Adverse events associated with corticosteroid therapy
Pregnancy & Lactation
- Consideration of administration during pregnancy and lactation
- Insufficient experience of use in human pregnancy and lactation
Precautions & Warnings
- Initiation in patients with stable asthma
- Relief medication availability for asthma patients
- Possibility of serious asthma-related adverse events
- Paradoxical bronchospasm
- Increased reporting of pneumonia in COPD patients
- Possible systemic effects of inhaled corticosteroid therapy
Use in Special Populations
- Potential impact on growth velocity in pediatric patients
- Effects on final adult height from reduction in growth velocity
Overdose Effects
- Signs and symptoms of Salmeterol overdose
- Signs and symptoms of Fluticasone Propionate overdose
- Treatment of Salmeterol overdose
- Monitoring of adrenal reserve for Fluticasone Propionate overdose
Therapeutic Class
- Long-acting selective β-adrenoceptor stimulants
- Respiratory corticosteroids
Storage Conditions
- Instructions for storage of pressurised canister
- Avoidance of puncturing, breaking, or incinerating
- Storage temperature and sunlight precautions
Related Brands
- Aroflo (25 mcg+125 mcg)/puff (Inhaler) - aristopharma-ltd
- Aroflo (25 mcg+250 mcg)/puff (Inhaler) - aristopharma-ltd
- Arotide (25 mcg+125 mcg)/puff (Inhaler) - eskayef-pharmaceuticals-ltd
- Arotide (25 mcg+250 mcg)/puff (Inhaler) - eskayef-pharmaceuticals-ltd
- Bexitrol F (25 mcg+50 mcg)/puff (Inhaler) - beximco-pharmaceuticals-ltd